[CHRS] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
02-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 42.67%
YoY- 23.84%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 77,063 91,524 74,568 58,716 32,436 45,352 45,424 42.20%
PBT 102,875 -79,653 -40,021 -42,869 -75,729 -58,870 -86,650 -
Tax 1,464 -10,611 -380 11,560 -949 7,377 6,201 -61.76%
NP 102,875 -79,653 -39,641 -42,869 -74,780 -66,247 -92,851 -
Tax Rate -1.42% - - - - - - -
Total Cost -25,812 171,177 114,209 101,585 107,216 111,599 138,275 -
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 133.49 -87.03 -53.16 -73.01 -230.55 -146.07 -204.41 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS 0.91 -0.71 -0.41 -0.49 -0.94 -0.85 -1.19 -
EPS Diluted 0.82 -0.71 -0.41 -0.49 -0.94 -0.85 -1.19 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.